NMD regulates the UPR signaling pathway
NMD is the translation-coupled mRNA degradation pathway that functionally eliminates the overproduction of truncated proteins both in the ER and in the cytosol. To test whether inhibition of NMD affects ER stress, three protein synthesis inhibitors with different mechanisms of translation inhibition were selected for treatment of HEK293T cells. Puromycin, an aminoacyl-tRNA analogue, causes premature termination of translation and leads to rapid polysome degradation. Cycloheximide binds to 80S ribosomes and prevents translocation of tRNA during translation. Both translational and NMD inhibitors led to the activation of phosphorylation of eIF2α, PERK and IRE1α and increased protein levels of XBP1s, ATF6 and CHOP. However, Harringtonine, which only blocks translational elongation without inhibiting NMD 25, neither caused the increase in eIF2α phosphorylation nor led to ER stress (Fig. 1A).
Next, three key factors, UPF1, UPF2 and UPF3B, were each depleted in HEK293T cells. In all UPF-depleted cells, phosphorylation of PERK and eIF2α and protein levels of ATF6, XBP1s, BiP and CHOP were apparently upregulated (Figs. 1B and 1C), similar to treatment with puromycin or cycloheximide. These data suggest that the maintenance of proper NMD function is critical for balancing the basal activation of the UPR pathway and consequently suppressing over-activation of ER stress. We then investigated the effect of NMD on apoptosis. In all three UPF-depleted cell lines, cell apoptosis was apparently increased (Figs. 1D and 1E). To address whether the inhibition of NMD-induced apoptosis was mediated by the activation of ER stress, the IRE1α inhibitor Kira6 was selected to treat the UPF-depleted cells. Kira6 is an imidazopyrazine-based small molecule that competitively binds the ATP-binding site of the kinase domain of IRE1α and blocks the kinase and RNase activities of IRE1α 26, 27. Cell apoptosis induced by NMD disruption is significantly alleviated by Kira6 treatment. This suggests that the high level of cell apoptosis upon NMD disruption is mediated by activation of ER stress, possibly through a branch of the IRE1α pathway.
Unique regulation role of UPF3B in IRE1α signaling pathway
Surprisingly, UPF3B has a distinct role in IRE1α phosphorylation compared to UPF1 and UPF2. In shUPF3B cells, IRE1α phosphorylation was apparently increased, but this was not the case in shUPF1 and shUPF2 cells. Instead, IRE1α phosphorylation was slightly further inhibited in shUPF2 cells (Fig. 2A). Knockdown of UPF1 or UPF2 slightly increased the protein level of UPF3B, but depletion of UPF3B had no effect on the levels of UPF1 and UPF2. Instead, the levels of IRE1α phosphorylation and XBP1s were strongly reduced in cells overexpressing UPF3B. In addition to two ER stress markers, the expression levels of two downstream effectors, BiP and CHOP, were also significantly lower than in normal cells (Fig. 2B).
Since UPF3B knockdown leads to apoptosis, the effects of UPF3B on apoptosis during ER stress were investigated. The ER stress inducer thapsigargin (Tg) was chosen to treat the cells. Tg is a sesquiterpene lactone that is permeable to cells and induces ER stress by specifically inhibiting the Ca2+-ATPase within the ER 28. The results showed that knockdown of UPF3B enhanced apoptosis induced by Tg treatment, but overexpression of UPF3B inhibited Tg-induced apoptosis (Fig. 2C-2E). This suggests that UPF3B is involved in the regulation of apoptosis induced by ER stress.
UPF3B uniquely affected the phosphorylation of IRE1α, rather than UPF1 and UPF2. It is interesting to explore the underlying mechanism by which UPF3B inhibits IRE1α phosphorylation. First, the endogenous interaction between IRE1α and UPF3B was confirmed by co-immunoprecipitation assays in both HEK293T cells and U2OS osteosarcoma cell lines (Figs. 2F and 2G). To exclude that the interaction between IRE1α and UPF3B is mediated by RNAs, since both are RNA binding proteins, cell lysates were pretreated with RNase A and IRE1α still immunoprecipitated UPF3B (Figure S1). This suggests that the interaction occurs in an RNA-independent manner. Immunofluorescence experiments and colocalization analysis demonstrated that UPF3B as a shuttle protein, partially colocalized with IRE1α at ER loci (Fig. 2H and S2). Taken together, these data suggest that UPF3B directly interacts with IRE1α at the ER and modulates the activation of the IRE1α-XBP1s branch.
UPF3B inhibits the phosphorylation of IRE1α by binding to its kinase domain
IRE1α is a transmembrane protein consisting of a sensory domain in the ER lumen, the transmembrane segments and two cytoplasmic side domains including the regulated kinase domain and the RNase domain 29, 30. UPF3B contains a conserved RNA recognition motif (RRM)-like domain that mediates interaction with the MIF4G (middle portion of eIF4G) domain of UPF2, a middle domain, and an EJC binding motif (EBM) 31. To investigate the structural requirements for IRE1α interaction with UPF3B, different domain deletions or truncation mutants for IRE1α (Fig. 3A) and UPF3B (Fig. 3B) were generate to analyze their interaction regions by co-immunoprecipitation assays and GST pulldown experiments. Among these IRE1α mutants, IRE1αΔKR, in which the kinase and RNase domains were deleted, did not interact with UPF3B. However, IRE1αΔR with the RNase domain deleted, IRE1αKR containing the kinase and RNase domains, and IRE1αK containing only the kinase domain interacted with UPF3B (Figs. 3C and 3D). This suggests that the kinase domain of IRE1α is the UPF3B binding site. In the UPF3B mutants, removal of the RRM-like domain abolished the interaction between UPF3B and IRE1α (Figs. 3E and 3F), suggesting that the RRM-like domain of UPF3B is the key motif for IRE1α and UPF3B interaction. This was further confirmed by two-way immunoprecipitation analysis between UPF3BRRM and IRE1αK in HEK293T cells (Fig. 3G). However, overexpression of UPF3BRRM alone only minimally suppressed IRE1α phosphorylation, in contrast to overexpression of UPF3BWT (Figure S3), suggesting that the full length of UPF3B is required for the modulation of IRE1α phosphorylation.
UPF3B prefers to bind unphosphorylated IRE1α
Tg and another ER stress inducer, tunicamycin (Tm), were chosen to treat the cells to investigate whether the interaction between IRE1α and UPF3B was affected under ER stress activation. Tm is a natural nucleoside antibiotic that induces ER stress by inhibiting the protein glycosylation pathway 32. When cells were treated with Tm (10 µg/mL) or Tg (2 µM) for 1 and 3 h, respectively, the phosphorylation level of IRE1α was significantly upregulated, but the expression level of UPF3B was not affected (Fig. 4A). However, interaction between IRE1α and UPF3B was significantly decreased in the cells treated with either Tm or Tg, and the strength of the interaction was negatively correlated with the phosphorylation level of IRE1α (Fig. 4B and S4). To investigate further whether the interaction was mainly between unphosphorylated IRE1α and UPF3B, two IRE1α inhibitors, STF-083010 and Kira6, were selected to test the interaction. Unlike Kira6, which inhibited the phosphorylation and kinase activity of IRE1α, STF-083010 forms a selective Schiff’s base with a catalytic lysine in the RNase active site of IRE1α and is a specific inhibitor of IRE1α endonuclease activity rather than kinase activity 33. Indeed, neither the phosphorylation of IRE1α nor the interaction between IRE1α and UPF3B appeared to be affected in STF-083010 treated cells, although the splicing form of XBP1 was slightly inhibited (Fig. 4C). In contrast, Kira6 treatment abolished the phosphorylation of IRE1α and the splicing of XBP1, and the interaction between IRE1α and UPF3B was strongly enhanced (Fig. 4C). This suggests that UPF3B preferentially binds to the kinase domain of IRE1α in the non-phosphorylation state.
The IRE1αD123P mutation, which abolishes IRE1α dimerization and activation 34, and the IRE1αK599A mutation in the ATP-binding pocket of the kinase domain 35 have been confirmed to inhibit the IRE1α phosphorylation. In contrast, the IRE1αK907A mutant was RNase-defective but caused high phosphorylation of IRE1α 36. These three functional mutants were used in comparison with IRE1α wild-type to further investigate the interaction between IRE1α and UPF3B (Fig. 4D). Consistent with previous studies, phosphorylation of IRE1α was strongly inhibited in the IRE1αD123P and IRE1αK599A mutants, but enhanced in the IRE1αK907A mutant. More importantly, the interaction was apparently stronger between UPF3B and IRE1αD123P or IRE1αK599A, but weaker between UPF3B and IRE1αK599A compared to the wild-type interaction (Fig. 4D). This further confirmed that phosphorylation of IRE1α abolishes the interaction with UPF3B. Since phosphorylation at Ser724 of IRE1α is the predominant activated form of the kinase, we substituted Ser724 of IRE1α with aspartic acid (designated IRE1αS724D) or alanine (IRE1αS724A) to mimic the retention or loss of its kinase activity, respectively. UPF3B has a much stronger interaction with IRE1αS724A, but a much weaker interaction with IRE1αS724D compared with IRE1αWT (Fig. 4E). In conclusion, the strength of the interaction between IRE1α and UPF3B was negatively correlated with the phosphorylation level of IRE1α (Figure S4). Next, a bimolecular fluorescence complementation (BiFC) assay was conducted to confirm the interaction. IRE1α-Vn173, IRE1αS724A-Vn173 and IRE1αS724D-Vn173 were co-transfected with UPF3B-Vn155 in U2OS cells, respectively. The results showed that the interaction was mainly in the cytoplasm, and the interaction was stronger in IRE1αS724A-Vn173 and UPF3B-Vn155 than IRE1αS724D-Vn173 (Fig. 4F), confirming the critical role of phosphorylation at Ser724 of IRE1α in the interaction between IRE1α and UPF3B.
BiP and UPF3B jointly control the activation of IRE1α
IRE1α contains four domains, including a sensory domain in the ER lumen, transmembrane segments and two domains in the cytoplasmic side: the regulated kinase domain and the RNase domain (Fig. 5A). BiP has been reported to interact with the sensory domain of IRE1α to attenuate its activation 37. Under Tm or Tg transient treatment for 1 h, BiP was suppressed, the phosphorylation of IRE1α was enhanced and accordingly, the interaction between BiP and IRE1α was attenuated (Fig. 5B). Restoration of BiP decreased IRE1α phosphorylation and enhanced the interaction between IRE1α and UPF3B (Fig. 5C). In si-BiP cells, the phosphorylation level of IRE1α was increased and the interaction between UPF3B and IRE1α was inhibited (Fig. 5D). These results suggest that BiP in the ER lumen affects the interaction of IRE1α and UPF3B in the cytoplasmic side possibly via modulation of IRE1α activation.
Overexpression of UPF3B downregulated the levels of phosphorylated IRE1α and BiP, and consequently reduced the interaction between IRE1α and BiP (Fig. 5E). This implies that UPF3B potentially affects the balance of ER stress by limiting the activation of IRE1α and the expression of BiP. During ER stress activation, the protein level of IRE1α was not affected in UPF3B-overexpressing cells, but the extent of IRE1α phosphorylation and the level of XBP1s were also much less increased compared to the normal cells (Figs. 2B, 5F-5G). The interactions between IRE1α and BiP were strongly suppressed due to the downregulation of BiP levels. This may be because UPF3B negates the phosphorylation of IRE1α via protein interactions in UPR and consequently suppresses the expression of BiP. In shUPF3B cells, phosphorylation of IRE1α was still inhibited by overexpression of BiP (Figure S5A), but the efficiency of inhibition was only achieved at higher levels of BiP expression than that in normal cells (Figure S5B). When siBiP was used in UPF3B knockdown cell lines, phosphorylated IRE1α was not further upregulated (Figure S5C). The results showed that UPF3B may have a concerted regulatory role in IRE1α phosphorylation together with BiP, but is not fully dependent on BiP expression. In the BiP knockdown cell lines, overexpression of UPF3B inhibited IRE1α phosphorylation (Figure S5D), indicating that the functions of UPF3B and BiP are independent and redundant in regulating the activity of IRE1α.
UPF2 contains three conserved MIF4G (middle part of eIF4G) structural domains 38, 39. UPF2 interacts with UPF3B through its third MIF4G structural domain (Fig. 5H) and with UPF1 through its C-terminus, forming the central component of the ternary UPF complex. When the UPF2 MIF4G-3 segment was overexpressed in cells (Fig. 5I), the interaction of UPF3B with IRE1α was apparently inhibited and the phosphorylation of IRE1α was increased. Furthermore, overexpression of UPF3B not only decreased the phosphorylation of IRE1α but also precipitated more UPF2 and IRE1α in a dose-dependent manner (Fig. 5J). Two UPF3B mutants 31, UPF3BK52E or UPF3BR56E, which disrupt the interaction of UPF2 with UPF3B, were applied to test the interaction between UPF3B and UPF2 or IRE1α. Either UPF3BK52E or UPF3BR56E enhanced the interaction between UPF3B and IRE1α, whereas the EJC binding domain deletion mutant had no such effect (Figure S6). Nevertheless, these mutants inhibited IRE1α phosphorylation compared to the control, suggesting that free UPF3B, rather than the intact NMD complex, plays an important role in suppressing IRE1α activation.
UPF3B attenuates IRE1α dimerization and oligomerization under ER stress
During ER stress, activated IRE1α forms higher order oligomers or clusters in stressed cells 40. Since UPF3B negates IRE1α activation in cells by direct interaction, it is interesting to confirm whether UPF3B restricts the oligomerization of IRE1α during ER stress. IRE1α-GFP was transfected into the control and the shUPF3B cells as an oligomerization indicator. Fluorescent aggregation of IRE1α-GFP was evident under both Tm and Tg treatment for 1 and 3 h, respectively (Fig. 6A), and was further enhanced in shUPF3B cells (Figs. 6B and 6C). Statistical analysis showed that a higher proportion, larger area and higher fluorescence intensity of aggregated clusters appeared in the shUPF3B cells compared to control cells (Figs. 6D and 6F). This suggests that UPF3B is required to negate the aggregation of IRE1α under ER stress. Activation of IRE1α depends on autophosphorylation induced by homodimerization. To address whether UPF3B affects IRE1α dimerization, two different tagged IRE1α, IRE1α-Flag and IRE1α-HA, were co-expressed in cells. The dimerization of IRE1α was strongly inhibited with the dosage correlating with the overexpression of UPF3B (Fig. 6G).
The phosphorylation and genetic mutation of UPF3B abolishes the interaction with IRE1α
A single nucleotide substitution, 478T > G, has been identified in exon 5 of the non-syndromic X-linked mental retardation (XLMR) family 24. This nucleotide change caused the conversion of the 160th tyrosine to aspartic acid (Y160D). The tyrosine residue at this site is conserved in UPF3B in plants and animals, implying its physiological importance for UPF3B function. However, the underlying pathogenesis remains unknown. We overexpressed two UPF3B mutants, UPF3BY160F and UPF3BY160D and immunoprecipitated endogenous IRE1α to detect the interactions between IRE1α and both mutants. UPF3BY160D showed a weaker interaction with IRE1α compared to UPF3BWT and UPF3BY160F (Fig. 7A), suggesting that UPF3BY160D losses the function to inhibit IRE1α activation in suppressing ER stress. The oligomerization of IRE1α was examined by complementation of UPF3BWT, UPF3BY160F or UPF3BY160D in shUPF3B cell lines under ER stress (Figure S7). Statistical analysis showed that in shUPF3B cells, the proportion, area and fluorescence intensity of aggregated IRE1α clusters were not suppressed by UPF3BY160D overexpression which was similar to control cells, but were apparently suppressed by complementation of UPF3BWT and UPF3BY160F under ER stress. Taken together, these data suggest that Y160D mutation may result in chronic high levels of ER stress, which may lead to some neurodevelopmental disorders.
Given that UPF3BY160D disrupts the interaction between UPF3B and IRE1α, which is similar to the conditions of ER stress activation, we hypothesized that not only IRE1α but also UPF3B is regulated by phosphorylation modifications in stress stimuli. First, we examined the changes in serine-threonine phosphorylation of UPF3B in response to ER stress induced by Tm or Tg for 3 h (Fig. 7B). The phosphorylation of UPF3B was increased in a time-dependent manner after 1, 3 or 6 h of Tg treatment, similar to the IRE1α phosphorylation (Fig. 7C). The results showed that the phosphorylation of UPF3B were enhanced in response to ER stress. To determine the site where UPF3B was phosphorylated, phosphorylation mapping mass spectrometry was applied to precipitated UPF3B from HEK293T cells (Fig. 7D). Among the six phosphorylation sites identified, T169, T197 or T198 phosphorylation sites were present in the RRM domain that interacts with IRE1α. To address the key phosphorylation sites, we made three pair mutants, UPF3BT169A and UPF3BT169D, UPF3BT197A and UPF3BT197D, and UPF3BT198A and UPF3BT198D, mimicking the unphosphorylated or phosphorylated status of UPF3B. The results showed that only UPF3BT169D significantly inhibited the interaction between IRE1α and UPF3B, which is similar to the genetic mutation of UPF3BY160D, while the mutations at the other two sites did not significantly alter the interaction (Figs. 7E-7G). In conclusion, the strength of the interaction between IRE1α and UPF3B was not only negatively correlated with the phosphorylation level of IRE1α, but also affected by the phosphorylation of UPF3B (Figure S8).
The interaction of UPF3BY160D with UPF2 was also inhibited compared to UPF3BWT and UPF3BY160F (Fig. 7H). Therefore, the UPF3BY160D mutant impaired the interaction of UPF3B with both IRE1α and UPF2. This raises the question whether XLMR parthenogenesis is due to the loss of the ability of UPF3BY160D to suppress ER stress or maintain NMD efficiency, or both. We therefore examined whether the potential phosphorylation site of UPF3B would affect its interaction with UPF2. UPF3BT169D also appeared to inhibit the interaction with UPF2 compared to UPF3BWT, UPF3BT197D and UPF3BT198D (Figs. 7H-7J). Also, the two mutations UPF3BY160D and UPF3BT169D, which are suppressed in the interaction with IRE1α, also attenuate the inhibition of apoptosis compared with the restoration of UPF3BWT, UPF3BY160F or UPF3BT169A, respectively, in shUPF3B cell lines under physiological conditions and during ER stress (Figs. 7K-7N).
The dual role of UPF3B in NMD and ER stress
Our study provides insights into the direct linkage via UPF3B interactions between two quality control pathways at the ER locus. Under physiological conditions, the monomeric IRE1α kinase endonuclease remains in an inactive form by binding to BiP at the sensory domain and UPF3B at the kinase domain on both sides of the ER lumen and cytoplasm. Upon ER stress, unfolded proteins compete with IRE1α for BiP, and stress-induced phosphorylation of UPF3B losses its ability to suppress IRE1α activation, allowing IRE1α to dimerize, activate its kinase activity and mediate its autophosphorylation, leading to regulated IRE1α-dependent decay. The dimerized IRE1α is further oligomerized, and forms foci that correlate with the activation of IRE1α-catalyzed splicing endonuclease activity. In conclusion, UPF3B plays an important role in negating UPR activation by suppressing the high-order oligomerization of IRE1α required for its activation by autophosphorylation. UPF3B is phosphorylated during ER stress, UPF3BT169 phosphorylation and the UPF3BY160D genetic mutation fail to interact with IRE1α and UPF2 and are unable to antagonize ER stress-induced apoptosis compared to UPF3BWT, which may be related to the pathogenesis in XLMR or other neuronal degenerative diseases. Overall, our data demonstrate that UPF3B plays a critical role in ER homeostasis by inhibiting the UPR and preventing ER stress-induced cell apoptosis.